Company: BSTZ
Filing Date: 2025-09-04
Form Type: N-CSRS
Source: 0001193125-25-196080
Chunk: 46

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-09-04
Form: N-CSRS
Chunk 46
---
 |
| (j) | Annualized 7-day yield as of period end.                                                                                                                                                                          |
| (k) | All or a portion of this security was purchased with the cash collateral from loanedsecurities.                                                                                                                   |

For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Trust for compliance purposes. 86 2025 BlackRock Semi-Annual Report to Shareholders

Consolidated Schedule of Investments (unaudited) (continued) June 30, 2025 BlackRock Science and Technology Term Trust (BSTZ)

Affiliates Investments in issuers considered to be affiliate(s) of the Trust during the six months ended June 30, 2025 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

| Affiliated Issuer                                       | Value at12/31/24 | Purchasesat Cost | Proceedsfrom Sales | NetRealizedGain (Loss) | Change inUnrealizedAppreciation(Depreciation) | Value at06/30/25 | SharesHeld at06/30/25 |     Income | Capital GainDistributionsfromUnderlyingFunds |
| BlackRock Cash Funds: Institutional, SL Agency Shares   |       $7,491,149 | $20,437,428(a)   | $—                 | $(3,497)               | $(893)                                        |      $27,924,187 |            27,913,021 | $94,504(b) | $—                                           |
| BlackRock Liquidity Funds, T-Fund, Institutional Shares |        2,010,552 | 21,059,146(a)    | —                  | —                      | —                                             |       23,069,698 |            23,069,698 |    396,525 | —                                            |
|                                                         |                  |                  |                    | $(3,497)               | $(893)                                        |      $50,993,885 |                       |   $491,029 | $—                                           |

| (a) | Represents net amount purchased (sold).                                                                                                                              |
| (b) | All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of collateral investment fees, and 
 other payments to andfrom borrowers of securities.                                                                                                                   |

Derivative Financial Instruments Outstanding as of Period End Exchange-Traded Options Written

| Description                            |